Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.452 SEK | -0.77% | -3.90% | -12.91% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Analyst Reco.
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Analyst Reco.